Skip to Main Content

Paper Details

Integrative analysis identifies an older female-linked AML patient group with better risk in ECOG-ACRIN Cancer Research Group's clinical trial E3999.
Blood Cancer J
1
2022
Author NameAffiliation
Martin S TallmanMemorial Sloan Kettering Cancer Center
Mithat GonenMemorial Sloan Kettering Cancer Center
Ari Melnick
Francine E Garrett-BakelmanUniversity of Virginia
Francine E Garrett-Bakelman
Francine E Garrett-BakelmanUniversity of Virginia
Francine E Garrett-BakelmanUniversity of Virginia Cancer Center
Francine E Garrett-BakelmanUniversity of Virginia
Francine E Garrett-Bakelman
Francine E Garrett-BakelmanUniversity of Virginia
Francine E Garrett-BakelmanUniversity of Virginia Cancer Center
  • 1 - 11

Datasets

Release 1.2